Literature DB >> 28667592

Intracranial granulocytic sarcoma as the first presentation of chronic myeloid leukemia in chronic phase.

Karuna Kabadi1, Parameswaran Anoop2, Venkatachala Sandhya3, Ganesh K Murthy1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28667592     DOI: 10.1007/s11060-017-2541-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  5 in total

1.  Granulocytic sarcoma in a patient with blast crisis mimicking a chronic subdural hematoma.

Authors:  Caitlin E O'Brien; Amanda M Saratsis; Jean-Marc Voyadzis
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

2.  Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis.

Authors:  Rebecca A Levy; Mabel A Mardones; Micah M Burch; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

3.  Intracranial granulocytic sarcoma (chloroma) may mimic a subdural hematoma.

Authors:  Martijn H Smidt; Hein G de Bruin; Mars B van't Veer; Martin J van den Bent
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.

Authors:  Jen-Fen Fu; Tzung-Hai Yen; Yu Chen; Ying-Jung Huang; Cheng-Lung Hsu; Der-Cherng Liang; Lee-Yung Shih
Journal:  Int J Cancer       Date:  2013-05-07       Impact factor: 7.396

5.  A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia.

Authors:  M Kobayashi; J Hamada; Y Q Li; N Shinobu; M Imamura; F Okada; N Takeichi; M Hosokawa
Journal:  Jpn J Cancer Res       Date:  1995-03
  5 in total
  1 in total

1.  Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma.

Authors:  Li Zhou; Xinhui Zhang; Shanglong Feng; Na Zhao; Xing Hu; Liangliang Huang; Changcheng Zheng
Journal:  Onco Targets Ther       Date:  2020-01-09       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.